ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
Additional ACG presentation to focus on impact of Xifaxan on OHE rehospitalizations LAVAL, QC / ACCESSWIRE / October 27, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), announced that results of an analysis of Xifaxan® (rifaximin) monotherapy will be presented during a Presidential Plenary Session of The American College of Gastroenterology® 2024 Annual Scientific Meeting taking place October 25-30 in Philadelphia, PA. This post hoc analysis of data from two randomized trials evaluated the efficacy of Xifaxan monotherapy compared to lactulose monotherapy for risk reduction of overt hepatic encephalopathy (OHE) recurrence and all-cause mortality.
Ryder System, Inc. (R) Q3 2024 Earnings Call Transcript
Ryder System, Inc. (NYSE:R ) Q3 2024 Earnings Conference Call October 24, 2024 11:00 AM ET Company Participants Calene Candela – Vice President, Investor Relations Robert Sanchez – Chairman and Chief Executive Officer John Diez – Executive Vice President and Chief Financial Officer Tom Havens – President, Fleet Management Solutions Steve Sensing – President, Supply Chain Solutions and Dedicated Transportation Solutions Conference Call Participants Jordan Alliger – Goldman Sachs Christyne McGarvey – Morgan Stanley Jeff Kauffman – Vertical Research Partners Scott Group – Wolfe Research Brian Ossenbeck – JPMorgan Daniel Imbro – Stephens Operator Good morning, and welcome to the Ryder System Third Quarter 2024 Earnings Release Conference Call. All lines are in a listen-only mode until after the presentation.
Ryder (R) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for Ryder (R) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ryder (R) Q3 Earnings Beat Estimates
Ryder (R) came out with quarterly earnings of $3.44 per share, beating the Zacks Consensus Estimate of $3.39 per share. This compares to earnings of $3.58 per share a year ago.
Atlantic Power & Infrastructure (AP&I) Emerges from Devastating Hurricanes with Upside Potential for Its Proprietary Flexi(R)-Pave
TAMPA, FL / ACCESSWIRE / October 23, 2024 / Due to recent storms that have devastated the Southeastern United States, Atlantic Power & Infrastructure Corp. (OTC PINK:AWSL) is experiencing a surge of interest in the incredible uses of Flexi®-Pave to mitigate stormwater management. According to Ryan Maue, the former Chief Scientist for the North Oceanic Atmospheric Administration, Hurricane Helene dumped approximately 40 trillion gallons of water in her path, stunning experts and leaving local communities in ruin in the aftermath that followed.
Will Ryder (R) Beat Estimates Again in Its Next Earnings Report?
Ryder (R) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Insights Into Ryder (R) Q3: Wall Street Projections for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Ryder (R), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
Ryder Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
R's third-quarter 2024 revenues are expected to have benefited from strength across all segments.
Tenon Medical(R) Announces Issuance of Three U.S. Patents
Further Solidifies International Patent Portfolio and Underscores the Company's Commitment to Innovation of SI Joint Stabilization Systems and Methods LOS GATOS, CA / ACCESSWIRE / October 17, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced the issuance of U.S. Patent Nos. 12,115,075, 12,115,076 and 12,115,077.
Ryder (R) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Ryder (R) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mace(R) Security International, a Global Leader in Personal Self-Defense Sprays, Announces Agreement and Plan of Merger
CLEVELAND, OH / ACCESSWIRE / October 16, 2024 / Mace Security International, Inc. (OTCQB:MACE) ("Mace") today, following an extensive strategic alternatives process, announced that Mace and W Electric Intermediate Holdings, LLC have entered into a definitive Agreement and Plan of Merger ("Merger Agreement") for a business combination that will result in Mace becoming a wholly-owned subsidiary of W Electric Intermediate Holdings, LLC. Headquartered in Pittsburgh, Pennsylvania, W Electric Intermediate Holdings, LLC is the parent company of a global brand operator and value-added distributor of consumer and industrial products.
Ryder Reaches 52-Week High: What's Supporting the Stock?
R stock appreciates more than 30% in the past 6 months on multiple tailwinds.
